Fajardo, Kyzine .

HRN: 21-48-96  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/28/2022
07/04/2022
IVTT
530mg
Q8
Pcap
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: